September 19, 2013
Holliston, MA -- The Oligo Factory, a provider of quality custom DNA/RNA synthesis services, announced plans to expand its facilities to accommodate growing market demand for mg to gram scale custom oligonucleotides, derivatives and modifications. The expanded facility will house additional synthesis and purification instrumentation and expand capacity to enable the company to serve its [...]
SAFC® Strengthens Biopharmaceutical Position With Innovations to Established CHOZN® Portfolio
September 19, 2013
ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services business unit, has engineered additional traits into its CHOZN® Platform cell line, increasing the utility of the CHOZN® portfolio of products and services. Two novel host cell lines have been added to the CHOZN® portfolio, yielded through SAFC's [...]
Agilent Technologies Names Robert Cantrell as Vice President and Treasurer
September 19, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced that Robert Cantrell has been named vice president and treasurer. Cantrell replaces Neil Dougherty, who is CFO-designate of the new electronic measurement company to be formed by the separation of Agilent into two publicly traded companies. In his new position, Cantrell will be responsible [...]
Bruker Announces the World’s First Preclinical Magnetic Particle Imaging (MPI) System
September 19, 2013
SAVANNAH, Ga. -- At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today announced the world's first Magnetic Particle Imaging (MPI) system, an entirely new technology for preclinical imaging. The addition of MPI as a complementary preclinical imaging technique for disease studies, translational research and drug discovery, has significant potential in helping researchers gain [...]
Cellectricon announces Cellaxess® ACE project grant winners
September 19, 2013
Molndal, Sweden -- Cellectricon, a leading provider of advanced cell-based screening technologies and services, has announced the two winners of its Cellaxess® ACE project grant, supporting cutting-edge research in cell biology. The grant was awarded for project proposals utilizing Cellectricon’s Cellaxess ACE technology for the delivery of non-genetic material to adherent cells and cultures. The [...]
Ehrfeld Mikrotechnik BTS and Alfa Laval cooperate in millireactor technology
September 18, 2013
Wendelsheim (Germany) – Ehrfeld Mikrotechnik BTS GmbH (EMB), a subsidiary of Bayer Technology Services GmbH, has acquired a worldwide license from Alfa Laval to market and manufacture ART® reactor technology. With these millistructured plate reactors, which are used in laboratory, pilot and production plants, EMB is now the leading supplier of metal micro- and millistructured [...]
Bruker Introduces New Multimodal Preclinical Imaging Animal Bed
September 18, 2013
SAVANNAH, Ga.-- Today, at the 2013 World Molecular Imaging Congress (WMIC), Bruker (NASDAQ: BRKR) introduced a new multimodal animal bed enabling multiple sequential imaging sessions in preclinical research with robust repositioning between scans, while avoiding unwanted motion of the animal during the investigation. This innovation optimizes results for image fusion, combined processing and evaluation of [...]
September 18, 2013
SAVANNAH, GA, USA -- Aspect Imaging, the world leading developer of compact high-performance MRI systems, today launched a complete line of compact MRI systems for a wide variety of pre-clinical applications. The three “M”-series compact MRI systems include the M10, a new compact MRI model for pre-clinical imaging of larger species and the M3, a [...]
September 18, 2013
ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today released a report on the state of academic translational research, a rapidly expanding field in which academic scientists aim to "translate" their laboratory discoveries to patient benefit. The first-of-its-kind survey was conducted by Sigma-Aldrich and the Association for the Advancement of Science (AAAS) and was completed by [...]
PROTEA & VCU IN MOLECULAR IMAGING RESEARCH PARTNERSHIP
September 18, 2013
SAVANNAH, Ga. -- Protea Biosciences Group, Inc. ("Protea") announced today that it has entered into a Collaborative Research Agreement with Virginia Commonwealth University ("VCU") and its Center for Molecular Imaging. The research focuses on the combination of LAESI, Protea's ex vivo molecular imaging mass spectrometry technology platform, with VCU's in vivo molecular PET, SPECT and [...]
